SUMMARY The pathogenesis and treatment of dysfunction of the continent ileostomy was investigated in 12 patients, five of whom had asymptomatic malabsorption and seven of whom had acute complaints. The number of anaerobic bacteria in jejunal aspirates was increased in patients with pouch malfunction (range 103 to 108/g aspirate), but the microbiology of ileal effluent and the morphology of the ileal mucosa could not be correlated with dysfunction. Bile acid breath tests and lactose tolerance tests were not, however, reliable indicators of jejunal bacterial overgrowth. The symptoms, the malabsorption, and the number of jejunal and ileal anaerobic bacteria decreased in patients during treatment with metronidazole, implicating overgrowth of anaerobic bacterial flora in the pathogenesis of the syndrome.
The continent ileostomy (ileal pouch), devised by Kock,' has been used as an alternative to conventional ileostomy for selected patients with ulcerative colitis and familial polyposis.2-5 The reservoir functions satisfactorily in most patients, but malfunction of the 'nipple valve' may occur in up to a third of patients and lead to incontinence. Improved surgical techniques appear, however, to have decreased the incidence of valvular dysfunction ;2 5 furthermore, better selection of patients should decrease the need for revision of prolapsed valves.6 Because Crohn's disease may recur after construction of a pouch,2 5 we believe that this diagnosis is a contraindication to the operation.2 5 T More recently other syndromes of ileostomy dysfunction have been reported. These are described variably as: 'stafnant loop syndrome',9 'enteritis' ,7 'pouchitis', " and 'non-specific ileitis'. 5 "I The corresponding clinical features may include diarrhoea,5 l0l2 malabsorption of fat and vitamin B12,9 12 proliferation of anaerobic bacteria in the pouch,9 inflammation in the pouch, 7 incontinence,"' difficulty with intubation,1' and bloody discharge. 5 We previously reported diarrhoea with some features of malabsorption in approximately one-third of asymptomatic patients with continent ileostomies. 12 Here, we extend these studies to include patients with symptoms of ileostomy dysfunction; we also examined the possible mechanisms for dysfunction and the symptomatic response to metronidazole. (Table 1) These patients were selected on the basis of documented malabsorption and/or symptoms of a malfunctioning pouch. Five subjects (nos 1-5) with diarrhoea and malabsorption had been identified earlier. 12 Their pouches were 'mature' (32-51 months postoperative, mean 40 months). On restudy, these five still had excess outputs of volume (>1000 g/day) and/or fat (Table 1) . Seven patients (nos [6] [7] [8] [9] [10] [11] [12] had symptoms of dysfunction of the operation (range, one to nine months; mean, five ileostomies constructed 2() to 58 months (mean, 38 months). Two were studied 32 and 33 months after months) previously. operation.
Methods

PATIENTS WITH POUCH DYSFUNCTION
All patients in the study had proctocolectomies performed for chronic ulcerative colitis. All gave CONTROL PATIENTS (Table 2) written, informed consent for the protocol that had In five patients (nos 13-17) with continent been approved by the Human Studies Committee of ileostomies, we had documented in a previous Mayo Clinic. The patients were hospitalised in the study12 normal pouch effluents (weight <1000 g/24 h Clinical Research Center. They were given constant and faecal fat <7 gl24 h), both of which were diets of known composition, designed to be similar confirmed. These subjects had had their pouches for to the usual dietary pattern at home, and including 35 to 63 months (mean, 50 months). A second 100 g fat. None was taking medication. One patient control group (Table 2) consisted of eight patients (no. 4), who was taking salicylazosulphapyridine, (nos 18-25) who had conventional (Brooke) discontinued the drug two weeks before the study. Campylobacter fetus ssp jejuni, Salmonella, and Shigella were sought specifically. Direct visual examination for presence of parasites was performed on each specimen. Faecal samples from nine of the patients with stomal dysfunction were examined for Clostridium difficile toxin (tests performed in the laboratory of Drs J W Chang and S L Gorbach).
BREATH TESTS
Bile acid breath tests were performed according to the method of Fromm and Hofmann. '6 Patients were fasted for 12 hours before receiving an oral dose of 5 uCi 1-4C-cholyl glycine in 240 ml Ensure (Ross Laboratories). Expired air was collected in hydroxide of hyamine before administration of the isotopes and then hourly for four hours after the bile acid was given. Trapped 14C02 was suspended in a Perma-fluor, Carbasoda (Packard Instruments) and quantified by counting against an external gamma standard in a Beckman LS 250 Scintillation Counter (Beckman Instruments).
Hydrogen breath tests were carried out after an oral dose of 50 g lactose in distilled water. '5 17 Expired air was collected for five minutes before and at hourly intervals for four hours after administration of lactose. Breath hydrogen was determined by gas chromatography. Simultaneous capillary blood samples were obtained before and at 15, 30 , and 60 minutes after lactose. Glucose concentrations were measured using the hexokinase assay (Hexokinase Kit, Beckman Instruments).
ENDOSCOPY AND BIOPSY OF ILEOSTOMY
Ileal pouches and their valves were examined using a Fujinon model FG, QBF fibreoptic endoscope. Biopsies were obtained under direct vision at several separate sites with an ACMI 7035A biopsy forceps. The posterior wall of the pouch directly opposite the valve was avoided, as it is the region most likely to suffer trauma from the catheter used to empty the pouch. Tissue for histology was prepared as described for jejunal biopsies and was also evaluated by WMW.
RESPONSE TO TREATMENT
Patients with pouch dysfunction were treated with metronidazole (250 mg tid) and measurements of faecal weight, faecal fat, and the Schilling test with intrinsic factor were repeated at the end of a seven or 14 day course of the antimicrobial. (Tables 1 and 2 ) Patients 1-5 had laboratory features of malabsorption but were essentially asymptomatic. Even on specific questioning, only minor or no symptoms could be elicited. Except for one patient (no. 6), patients with symptoms (nos 6-12) had high faecal weights (>1000 g/24 h) and/or excessive faecal fat. All control patients (Table 2) had normal faecal weights and fat excretions except patient no. 18 who had an increased faecal weight. Four patients (nos 1, 5, 8, 12) had abnormal Schilling tests (<9% ingested dose). All patients had normal serum vitamin B12 levels. Other laboratory tests were normal or showed changes expected after proctocolectomy (mild systemic acidosis, mild hyperchloraemia). Two patients (nos 2 and 4) had abnormalities compatible with a diagnosis of liver disease associated with ulcerative colitis; these were longstanding and antedated proctocolectomy.
Jejunal histology was normal in all patients from whom tissue was available for interpretation, with one exception. Patient no. 2 had normal villous architecture but a mild increase of inflammatory (round) cells in the lamina propria and a single crypt abscess. Jejunal histology was not evaluated from three control patients (nos 17, 19, 24) and two in the dysfunction group (nos 8 and 11).
MICROBIOLOGY OF JEJUNUM AND ILEAL EFFLUENT
In jejunal aspirates the numbers of total bacteria, aerobic and anaerobic, were larger for the patients with dysfunction than for either of the control groups. Numbers of anaerobic bacteria are shown in Fig. 1 As expected, metronidazole decreased the number of anaerobic organisms in both jejunal and stomal specimens (Figs 1 and 2 ). Aerobic bacteria diminished in jejunal aspirates but increased in ileal effluent.
Eleven biopsies of pouch mucosa were obtained from eight patients after metronidazole. One patient (no. 1) whose pretreatment mucosal biopsy revealed inflammation had a normal biopsy after treatment. All others were unchanged by treatment.
FOLLOW-UP
Responses to a follow-up questionnaire indicated that four of 12 patients (nos 3. 4 There are several practical implications of the present study. When pouch function is disturbed, mechanical failure of the 'nipple valve' should be sought by endoscopy and barium studies. A positive diagnosis requires corrective re-operation. Endoscopy might also suggest an alternative aetiology and, although histology is not a reliable guide to inflammation in the pouch, biopsies should be obtained to look for recurrent Crohn's disease. Quantitative faecal outputs of fat and volume should be performed to document malabsorption if present. Faecal cultures and microscopy will be needed to exclude specific pathogens27 and/or toxins but we found that the identification of faecal ecology was unhelpful in contrast with the experience of others.9 9 Empirical treatment of pouch dysfunction with antimicrobials may be reasonable, though efficacy should be monitored by repeating appropriate studies after treatment. If one antibiotic faills, another may succeed and some patients will require repeated courses of antibiotics. Given that a lifetime with an ileal pouch is to be expected, the occurrence of evenl borderline malabsorption cannot be ignored though the significance is still uncertain. 
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